Unlocking hidden insights from a simple sample—changing how we see cancer detection forever Rethinking Urological Cancer Detection
Three of the top 10 most common cancers globally affect the urological system, yet current diagnostics often miss early signs or lead to invasive, unnecessary procedures. We at TrueScreen r2b is about to change this. Imagine a world where detection is precise, fast, and non-invasive, all from one simple sample. No pain, no wait, no interventions unless they’re needed. Our technology redefines what’s possible, offering insights that can alter treatment paths before it’s too late.
Check out our rockstar contributors community and meet the people behind Sesamers!
Sesamers is the insiders advantage to professional events.
By category
By country
Stay at the forefront with our curated guide to the best upcoming Tech events.